Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc.（ATNM）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
atnm · 股价预测 · 11 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$24.26
Consensus
$11.07
+944.3% upside
Low
$4.00
Median: $4.95 · Last Close: $1.06
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$11.07
944.3% upside
High Target
$24.26
2188.7%
Low Target
$4
277.4%
Current Price
$1.06
as of today
Based on analyst price targets, the ATNM stock price prediction for the next 12 months ranges from $4 to $24.26. The consensus ATNM price forecast of $11.07 implies 944.3% upside from the current price of $1.06.
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.03 | ↓ 3.26% |
1-day model range: $1.01–$1.04. Peak: $1.04 (-3.26%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · ATNM · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-31 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2025-06-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Actinium Pharmaceuticals, Inc. (ATNM) stock. Of the recent 40 rating actions, 0 were upgrades and 0 were downgrades. 11 analysts currently cover ATNM.
分析师推荐趋势
ATNM analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$13M
↓ 54.3% YoY
Revenue Next Year
$13M
↑ 0.1% YoY
EPS This Year
$-0.83
EPS Next Year
$-0.79
↓ 4.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast ATNM EPS of $-0.83 for the current fiscal year, based on estimates from 1 analysts. The ATNM revenue forecast is $13M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ATNM 股价预测由两类独立数据源支撑：来自 11 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ATNM 的共识目标价为 $11.07（+944.3% 上行空间），分析师共识为 Buy。
ATNM 的短期预测（明日）为 $1.03（-3.26%）。 ATNM 对 2030 年的预测区间为 $0–$0。
Actinium Pharmaceuticals, Inc. 在 AMEX 上市，代码 ATNM。ATNM 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
ATNM 预测 · 8 个问题根据 11 位华尔街分析师，ATNM 的 12 个月平均目标价为 $11.07，最高 $24.26、最低 $4.00。若有图表，中位目标价可在上方查看。相对当前价 $1.06，隐含约 +944.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.